1. Home
  2. CPSH vs ENTX Comparison

CPSH vs ENTX Comparison

Compare CPSH & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$5.21

Market Cap

68.9M

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.76

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSH
ENTX
Founded
1984
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
58.2M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
CPSH
ENTX
Price
$5.21
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$9.00
AVG Volume (30 Days)
1.8M
3.0M
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
113.64
N/A
EPS
N/A
0.07
Revenue
N/A
$42,000.00
Revenue This Year
$16.41
N/A
Revenue Next Year
$20.16
N/A
P/E Ratio
N/A
$23.71
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$0.91
52 Week High
$14.39
$3.22

Technical Indicators

Market Signals
Indicator
CPSH
ENTX
Relative Strength Index (RSI) 42.13 65.97
Support Level $4.61 $1.45
Resistance Level $5.50 $1.94
Average True Range (ATR) 0.68 0.27
MACD -0.21 0.04
Stochastic Oscillator 9.97 32.10

Price Performance

Historical Comparison
CPSH
ENTX

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: